Bulletin
Investor Alert

New York Markets Open in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Jan 27, 2023, 3:59 p.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.89

Change

0.00 0.00%

Volume

Volume 7,800

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.89

$ 1.89

Change

0.00 0.00%

Day low

Day high

$1.85

$1.91

Open

52 week low

52 week high

$0.88

$3.45

Open

Insider Actions for Medexus Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/20/2022 Stephen Nelson
24,284   0
12/20/2022 Michael Peter Mueller
3,028   0
12/20/2022 Adele M. Gulfo
1,168   0
12/13/2022 Kenneth d’Entremont
16,000   1,664,000
12/13/2022 Kenneth d’Entremont
4,000   7,640
12/13/2022 Kenneth d’Entremont
16,000   1,664,000
12/13/2022 Kenneth d’Entremont
5,000   520,000
12/13/2022 Kenneth d’Entremont
4,000   7,640
12/13/2022 Kenneth d’Entremont
16,000   30,720
12/13/2022 Kenneth d’Entremont
16,000   30,720
12/13/2022 Kenneth d’Entremont
1,200   2,304
12/12/2022 Kenneth d’Entremont
16,000   1,664,000
12/12/2022 Kenneth d’Entremont
4,000   7,640
11/18/2022 Michael Peter Mueller
24,595   0
11/18/2022 Benoit Gravel
25,847   0
09/22/2022 Michael D. Adelman
6,400   7,296
09/21/2022 Kenneth d’Entremont
10,000   11,900
09/21/2022 Michael D. Adelman
22,400   25,536
09/20/2022 Glenn Tate
10,000   11,900
09/20/2022 Marcel Konrad
6,000   6,660
09/20/2022 Marcel Konrad
5,000   6,450
09/16/2022 Adele M. Gulfo
10,052   0
08/25/2022 Kenneth d’Entremont
37,794   0
06/28/2022 Kenneth d’Entremont
10,000   20,000
06/28/2022 Marcel Konrad
6,320   9,732

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
5 Purchases
10 Sales
78,922
98,200
Last 6 months
13 Purchases
10 Sales
186,568
98,200
Last 12 months
16 Purchases
10 Sales
204,809
98,200

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.